Last reviewed · How we verify
Thyroxin, Triiodothyronine
At a glance
| Generic name | Thyroxin, Triiodothyronine |
|---|---|
| Sponsor | University Hospital Freiburg |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Novel Approaches to the Treatment of Hypothyroidism (PHASE2, PHASE3)
- T4/T3 Therapy in Hypothyroidism (PHASE2)
- Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment (PHASE3)
- Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
- 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma (PHASE2)
- Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease (PHASE1, PHASE2)
- Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC (PHASE3)
- Treatment of ARDS With Instilled T3 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |